Skip to main content
GNW
NYSE Finance

Genworth Posts $0.11 Q3 Loss as Long-Term Care Charges and a $150M Tax Valuation Allowance Bite

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$8.91
Mkt Cap
$3.367B
52W Low
$7.84
52W High
$10.69
52W Position info
14% above low
Off High info
17% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

GNW is trading near its 52-week low of $7.84 (14% above the low).

Summary

Genworth lost $41 million, or $0.11 a share, in Q3 2026 as long-term care reserve charges deepened, the legacy RBC ratio fell to about 274% and a $150 million tax valuation allowance was booked; management warned the Q4 assumption review could be materially unfavorable.


Key Events · Earnings and Guidance · GNW

  • Q3 Swings to $0.11 Loss

    Net loss available to common stockholders was $41 million, or $(0.11) per diluted share, versus net income of $116 million ($0.28) a year earlier; adjusted operating income excluding Closed Block was $102 million vs $113 million.

  • Long-Term Care Charges Deepen

    Closed Block adjusted operating loss widened to $146 million from $96 million, and the long-term care liability remeasurement loss reached $264 million for the nine months versus $145 million, driven by lower terminations and higher claims.

  • RBC Ratio Falls to ~274%

    The consolidated risk-based capital ratio of the legacy insurance subsidiaries dropped to approximately 274% from 300% at December 31, 2025, mainly on a statutory loss in long-term care.

  • $150M Tax Valuation Allowance

    An additional $150 million valuation allowance on capital deferred tax assets was recorded through OCI in Q3 2026, lifting the total allowance to $702 million from $545 million.


Analysis · GNW · Finance

The headline is a $41 million quarterly loss, down from $116 million of income a year ago, but the real damage sits in the Closed Block. Long-term care drove a $264 million liability remeasurement loss for the nine months versus $145 million, and the segment's adjusted operating loss widened to $146 million from $96 million. Two balance-sheet items matter more than the headline. The legacy insurance subsidiaries' risk-based capital ratio fell to roughly 274% from 300% at year-end, and the company added $150 million to its valuation allowance on capital deferred tax assets through OCI because rising rates shrank unrealized gains available to offset capital losses. Management also pre-flagged that the fourth-quarter annual assumption review could be materially unfavorable, largely on long-term care cost-of-care inflation and utilization — the next hard datapoint for this story. Enact remains the cash engine, with a 158% PMIERs sufficiency ratio and $122 million of capital returned in the quarter, and buybacks continued into October.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1407 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GNW was trading at $8.91 on NYSE in the Finance sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $7.84 to $10.69. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GNW - Latest Insights

GNW
Nov 04, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $9.19
Real-time Price: $8.91 info
Change: -$0.280 (-3%) info
Market Cap: $3.367B info
GNW
Oct 30, 2026, 7:15 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $8.94
Real-time Price: $8.91 info
Change: -$0.030 (-0.34%) info
Market Cap: $3.367B info
GNW
Sep 15, 2026, 8:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $9.93
Real-time Price: $8.91 info
Change: -$1.02 (-10%) info
Market Cap: $3.367B info
GNW
Sep 02, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.21
Real-time Price: $8.91 info
Change: -$1.30 (-13%) info
Market Cap: $3.367B info
GNW
Jul 07, 2026, 4:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $9.31
Real-time Price: $8.91 info
Change: -$0.400 (-4%) info
Market Cap: $3.367B info